Centrus Energy Corp. announced that the U.S. Nuclear Regulatory Commission (NRC) approved the Company’s license amendment request to produce High-Assay, Low-Enriched Uranium (HALEU) at the Piketon, Ohio, enrichment facility. The Piketon plant is now the only U.S. facility licensed to enrich uranium up to 20 percent Uranium-235 (U-235) and expects to begin demonstrating HALEU production early next year.
BETHESDA, Md. - Centrus Energy Corp. (NYSE American: LEU) is providing an update on construction of the nation’s first production facility for High-Assay, Low-Enriched Uranium (HALEU) in Piketon, Ohio.
“Despite the impact of the pandemic and the extraordinary steps we have taken to protect our workforce – including limiting the number of people who can be on the construction site at any one time – we have kept construction on track and expect to begin producing HALEU by next year,” said Centrus President and CEO Daniel B. Poneman. “We believe this first-of-a-kind facility can play a critical role in meeting both government and commercial requirements for HALEU, powering America’s nuclear leadership as the world turns to a new generation of advanced reactors and advanced nuclear fuels.”
“Despite the unprecedented health crisis posed by COVID-19, with a large portion of our staff shifting to telework, Centrus has had a great year that saw us return to profitability, improve our balance sheet, and deliver value to stockholders with a higher share price,” said Daniel Poneman, Centrus President and Chief Executive Officer. “Our technical solutions team continues to make strong progress on the High-Assay, Low-Enriched Uranium (HALEU) program and we expect to begin demonstrating production of HALEU by early next year. Our sales team also secured over $100 million in new commitments from November through the end of January.”
Christopher Hanson is a highly qualified, experienced, and widely respected regulator. He is a great choice to lead the NRC at such an important time, as the agency continues to modernize and as a new generation of advanced reactors with inherent safety features move through the licensing process.